NANEXA Share Price | Nanexa AB Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

With a growth in Net Sales of 6208.18%, the company declared Outstanding results in Dec 25

OPERATING CASH FLOW(Y) Highest at SEK -1.46 MM
NET SALES(HY) Higher at SEK 30.57 MM
ROCE(HY) Highest at -13.21%

Risky -

Market Beating Performance

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

SEK 632 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.43

Return on Equity

-11.22%

Price to Book

6.22

Revenue and Profits:

Net Sales:

30 Million

(Quarterly Results - Dec 2025)

Net Profit:

16 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

201.24%

6 Months

26.04%

1 Year

294.57%

2 Years

3.12%

3 Years

45.78%

4 Years

-37.41%

5 Years

-57.44%

Nanexa AB for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

72.45%

EBIT Growth (5y)

4.99%

EBIT to Interest (avg)

-42.63

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.29

Sales to Capital Employed (avg)

0.26

Tax Ratio

0.35%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.51

EV to EBIT

-7.96

EV to EBITDA

-11.74

EV to Capital Employed

4.17

EV to Sales

17.95

PEG Ratio

Dividend Yield

ROCE (Latest)

-52.34%

ROE (Latest)

-34.42%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 5,920.00% vs -81.48% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 228.00% vs -111.86% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "30.10",
          "val2": "0.50",
          "chgp": "5,920.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "20.40",
          "val2": "-8.90",
          "chgp": "329.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "0.70",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "16.00",
          "val2": "-12.50",
          "chgp": "228.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "570.00%",
          "val2": "-25,230.60%",
          "chgp": "2,580.06%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 47.95% vs -16.72% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 54.22% vs 67.41% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "36.10",
          "val2": "24.40",
          "chgp": "47.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.90",
          "val2": "-20.80",
          "chgp": "86.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.10",
          "val2": "0.50",
          "chgp": "520.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-11.40",
          "val2": "-24.90",
          "chgp": "54.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-427.70%",
          "val2": "-1,082.80%",
          "chgp": "65.51%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

30.10

0.50

5,920.00%

Operating Profit (PBDIT) excl Other Income

20.40

-8.90

329.21%

Interest

0.70

Exceptional Items

0.00

Consolidate Net Profit

16.00

-12.50

228.00%

Operating Profit Margin (Excl OI)

570.00%

-25,230.60%

2,580.06%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 5,920.00% vs -81.48% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 228.00% vs -111.86% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

36.10

24.40

47.95%

Operating Profit (PBDIT) excl Other Income

-2.90

-20.80

86.06%

Interest

3.10

0.50

520.00%

Exceptional Items

0.00

Consolidate Net Profit

-11.40

-24.90

54.22%

Operating Profit Margin (Excl OI)

-427.70%

-1,082.80%

65.51%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 47.95% vs -16.72% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 54.22% vs 67.41% in Dec 2024

All Annual Results

Company CV

About Nanexa AB

Nanexa AB

Pharmaceuticals & Biotechnology

Nanexa AB is a Sweden-based company engaged in the drug delivery systems industry. The Company specializes in the nanotechnology and research and development in life science. Its products portfolio is comprised of PharmaShell, a drug delivery system that allows for targeting and dosing of drugs; antifungal coating, a system that protects medical products from the in-growth of fungi; and low-friction coating for peripheral venous catheters.

Company Coordinates

Company Details

Virdings Alle 32B , UPPSALA None : 754 50

Tel: 46 18 100300

http://www.nanexa.com/

Registrar Details